Shares of Tilray Inc (NASDAQ:TLRY – Get Free Report) traded down 0.9% on Wednesday . The company traded as low as $1.65 and last traded at $1.67. 9,949,430 shares changed hands during mid-day trading, a decline of 60% from the average session volume of 25,081,475 shares. The stock had previously closed at $1.68.
Tilray Stock Up 0.3 %
The stock has a market cap of $1.30 billion, a P/E ratio of -3.78 and a beta of 2.13. The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The stock’s 50-day moving average is $1.79 and its 200-day moving average is $1.88.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). The company had revenue of $229.90 million during the quarter, compared to analysts’ expectations of $226.20 million. Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. Tilray’s revenue for the quarter was up 24.8% compared to the same quarter last year. During the same period last year, the company earned ($0.15) earnings per share. As a group, research analysts anticipate that Tilray Inc will post -0.16 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Tilray
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Articles
- Five stocks we like better than Tilray
- Where to Find Earnings Call Transcripts
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- How to Use the MarketBeat Excel Dividend Calculator
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- Stock Average Calculator
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.